TipRanks
Sarepta Therapeutics (DE:AB3A)
FRANKFURT:AB3A

Compare Sarepta Therapeutics (AB3A) vs. Competitors

6 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Sarepta Therapeutics
€13.76
€1.65B
-12.15
-18.37%
4 Buy
9 Hold
4 Sell
Hold
Ultragenyx Pharmaceutical
$26.46
$1.50B
-2.48
-53.54%
10 Buy
10 Hold
0 Sell
Moderate Buy
uniQure
$51.05
$1.63B
-5.64
-58.49%
7 Buy
2 Hold
0 Sell
Strong Buy
Wave Life Sciences
$5.25
$744.84M
-3.44
-47.55%
12 Buy
1 Hold
0 Sell
Strong Buy
Solid Biosciences
$9.89
$734.49M
-3.70
19.66%
10 Buy
0 Hold
0 Sell
Strong Buy
Taysha Gene Therapies
$6.02
$1.51B
-10.62
-5.67%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:AB3A
Sarepta Therapeutics
15.44
-4.42
-22.28%
RARE
Ultragenyx Pharmaceutical
14.50
-15.69
-51.97%
QURE
uniQure
22.80
-30.11
-56.91%
WVE
Wave Life Sciences
3.75
-3.47
-48.06%
SLDB
Solid Biosciences
7.06
1.58
28.83%
TSHA
Taysha Gene Therapies
4.49
0.07
1.58%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts